tradingkey.logo

tradingkey.logo
怜玢


BIOAGE Labs Inc

BIOA
りォッチリストに远加
5.550USD
-0.100-1.77%
終倀 11-13 16:00ET
254.75M時䟡総額
損倱額盎近12ヶ月PER

BIOAGE Labs Incに぀いお 䌁業名

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its lead product is BGE-102, a structurally novel, orally available small molecule NLRP3 inhibitor with high potency and brain penetration. In preclinical obesity models, BGE-102 resulted in weight loss as both a monotherapy and in combination with a GLP-1R agonist. Its pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel APJ agonists for metabolic disorders. In preclinical obesity models, APJ agonism has demonstrated the ability to more than double the weight loss induced by a GLP-1R agonist while also restoring healthy body composition and improving muscle function.

BIOAGE Labs Inc プロフィヌル


䌁業コヌドBIOA
䌚瀟名BIOAGE Labs Inc
䞊堎日Sep 26, 2024
最高経営責任者「CEO」Fortney (Kristen)
埓業員数62
蚌刞皮類Ordinary Share
決算期末Sep 26
本瀟所圚地5885 Hollis Street
郜垂EMERYVILLE
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号94608
電話番号15108061445
りェブサむトhttps://bioagelabs.com
䌁業コヌドBIOA
䞊堎日Sep 26, 2024
最高経営責任者「CEO」Fortney (Kristen)

BIOAGE Labs Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kristen Fortney, Ph.D.
Dr. Kristen Fortney, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
976.95K
--
Dr. Dov A. Goldstein, M.D.
Dr. Dov A. Goldstein, M.D.
Chief Financial Officer
Chief Financial Officer
36.58K
+9.68%
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Independent Director
Independent Director
3.00K
--
Dr. Eric Morgen, M.D.
Dr. Eric Morgen, M.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Paul D. Rubin, M.D.
Dr. Paul D. Rubin, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Michael Harvey Davidson, M.D.
Dr. Michael Harvey Davidson, M.D.
Independent Director
Independent Director
--
--
Mr. Patrick G. Enright
Mr. Patrick G. Enright
Independent Director
Independent Director
--
--
Dr. James I. Healy, M.D., Ph.D.
Dr. James I. Healy, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Vijay Pande, Ph.D.
Dr. Vijay Pande, Ph.D.
Independent Director
Independent Director
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Kristen Fortney, Ph.D.
Dr. Kristen Fortney, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
976.95K
--
Dr. Dov A. Goldstein, M.D.
Dr. Dov A. Goldstein, M.D.
Chief Financial Officer
Chief Financial Officer
36.58K
+9.68%
Ms. Rekha Hemrajani
Ms. Rekha Hemrajani
Independent Director
Independent Director
3.00K
--
Dr. Eric Morgen, M.D.
Dr. Eric Morgen, M.D.
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Dr. Paul D. Rubin, M.D.
Dr. Paul D. Rubin, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Dr. Jeanpierre (JP) Garnier, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--

よくある質問

BIOAGE Labs Incの䞊䜍5名の株䞻は誰ですか


BIOAGE Labs Incの䞊䜍5名の株䞻は以䞋のずおりです。Dr. Kristen Fortney, Ph.D.

BIOAGE Labs IncBIOAの株匏を保有しおいる機関の数はいく぀ですか


2026Q1時点で、BIOAGE Labs Incの株匏を保有しおいる機関は243瀟あり、保有株匏の総垂堎䟡倀は玄28.69Mで、党䜓の65.54%を占めおいたす。2025Q4ず比范しお、機関の持ち株は-3087692.00増加しおいたす。
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。